Alzheimer's disease natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 27: Line 27:
Individual [[prognosis]] is difficult to assess due to the variability of the duration of the disease. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years.
Individual [[prognosis]] is difficult to assess due to the variability of the duration of the disease. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years.


The early stages of Alzheimer's disease are difficult to diagnose. A definitive diagnosis is usually made once cognitive impairment compromises everyday activities, although the person may still be living independently. People with Alzheimer's disease progress from mild cognitive problems, such as memory loss, through increasing stages of cognitive and non-cognitive disturbances, eliminating any possibility of independent living.<ref name="pmid10653284">{{cite journal |author=Förstl H, Kurz A |title=Clinical features of Alzheimer's disease |journal=[[European Archives of Psychiatry and Clinical Neuroscience]] |volume=249 |issue=6 |pages=288–90 |year=1999 |pmid=10653284 |doi= |url=http://link.springer.de/link/service/journals/00406/bibs/9249006/92490288.htm |accessdate=2012-08-16}}</ref>
The early stages of Alzheimer's disease are most difficult to diagnose. A definitive diagnosis is usually made once [[cognitive impairment]] compromises everyday activities, although the patient may still be living independently. People with Alzheimer's disease progress from mild cognitive problems, such as [[memory loss]], through increasing stages of cognitive and non-cognitive disturbances, eliminating any possibility of independent living.<ref name="pmid10653284">{{cite journal |author=Förstl H, Kurz A |title=Clinical features of Alzheimer's disease |journal=[[European Archives of Psychiatry and Clinical Neuroscience]] |volume=249 |issue=6 |pages=288–90 |year=1999 |pmid=10653284 |doi= |url=http://link.springer.de/link/service/journals/00406/bibs/9249006/92490288.htm |accessdate=2012-08-16}}</ref>


[[Life expectancy]] of the population with the disease is reduced.<ref name="pmid3776457">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Survival and cause of death in Alzheimer's disease and multi-infarct dementia |journal=[[Acta Neurologica Scandinavica]] |volume=74 |issue=2 |pages=103–7 |year=1986 |month=August |pmid=3776457 |doi= |url= |accessdate=2012-08-16}}</ref><ref name="pmid8757016">{{cite journal
[[Life expectancy]] of the population with the disease is reduced.<ref name="pmid3776457">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Survival and cause of death in Alzheimer's disease and multi-infarct dementia |journal=[[Acta Neurologica Scandinavica]] |volume=74 |issue=2 |pages=103–7 |year=1986 |month=August |pmid=3776457 |doi= |url= |accessdate=2012-08-16}}</ref><ref name="pmid8757016">{{cite journal
Line 49: Line 49:
|month=February
|month=February
|pmid=12580712
|pmid=12580712
}}</ref> The mean life expectancy following diagnosis is approximately seven years.<ref name="pmid7793228">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia |journal=[[Acta Neurologica Scandinavica]] |volume=91 |issue=3 |pages=159–64 |year=1995 |month=March |pmid=7793228 |doi= |url= |accessdate=2012-08-16}}</ref> Fewer than 3% of patients live more than fourteen years.<ref name="pmid7793228"/> Disease features significantly associated with reduced survival are an increased severity of cognitive impairment, decreased functional level, history of falls, and disturbances in the neurological examination. Other coincident diseases such as [[Heart disease|heart problems]], [[Diabetes mellitus|diabetes]] or history of [[alcohol abuse]] are also related with shortened survival.<ref name="pmid8757016"/><ref name="pmid15068977">{{cite journal
}}</ref> The mean [[life expectancy]] following diagnosis is approximately seven years.<ref name="pmid7793228">{{cite journal |author=Mölsä PK, Marttila RJ, Rinne UK |title=Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia |journal=[[Acta Neurologica Scandinavica]] |volume=91 |issue=3 |pages=159–64 |year=1995 |month=March |pmid=7793228 |doi= |url= |accessdate=2012-08-16}}</ref> Fewer than 3% of patients live more than fourteen years.<ref name="pmid7793228"/> Disease features significantly associated with reduced survival are an increased severity of cognitive impairment, decreased functional level, history of falls, and disturbances in the [[neurological examination]]. Other coincident diseases such as [[Heart disease|heart problems]], [[Diabetes mellitus|diabetes]] or history of [[alcohol abuse]] are also related with shortened survival.<ref name="pmid8757016"/><ref name="pmid15068977">{{cite journal
|author=Larson EB, Shadlen MF, Wang L, ''et al''
|author=Larson EB, Shadlen MF, Wang L, ''et al''
|title=Survival after initial diagnosis of Alzheimer disease
|title=Survival after initial diagnosis of Alzheimer disease

Revision as of 18:19, 7 November 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Alzheimer's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alzheimer's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Alzheimer's disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alzheimer's disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alzheimer's disease natural history, complications and prognosis

CDC on Alzheimer's disease natural history, complications and prognosis

Alzheimer's disease natural history, complications and prognosis in the news

Blogs on Alzheimer's disease natural history, complications and prognosis

Directions to Hospitals Treating Alzheimer's disease

Risk calculators and risk factors for Alzheimer's disease natural history, complications and prognosis

Overview

Alzheimer's disease is a slow-progressing condition that involves complications such as the inability to take care of oneself. There is no cure for Alzheimer's disease; patients typically pass away from a cause associated with the condition.

Complications

Potential complications of Alzheimer's disease include:

Prognosis

Individual prognosis is difficult to assess due to the variability of the duration of the disease. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years.

The early stages of Alzheimer's disease are most difficult to diagnose. A definitive diagnosis is usually made once cognitive impairment compromises everyday activities, although the patient may still be living independently. People with Alzheimer's disease progress from mild cognitive problems, such as memory loss, through increasing stages of cognitive and non-cognitive disturbances, eliminating any possibility of independent living.[1]

Life expectancy of the population with the disease is reduced.[2][3][4] The mean life expectancy following diagnosis is approximately seven years.[5] Fewer than 3% of patients live more than fourteen years.[5] Disease features significantly associated with reduced survival are an increased severity of cognitive impairment, decreased functional level, history of falls, and disturbances in the neurological examination. Other coincident diseases such as heart problems, diabetes or history of alcohol abuse are also related with shortened survival.[3][6][7] While the earlier the age at onset the higher the total survival years, life expectancy is particularly reduced when compared to the healthy population among those who are younger.[4] Men have a less favourable survival prognosis than women.[5][8] Pneumonia and dehydration are the most frequent immediate causes of death, while cancer is a less frequent cause of death than in the general population.[2][8]

References

  1. Förstl H, Kurz A (1999). "Clinical features of Alzheimer's disease". European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–90. PMID 10653284. Retrieved 2012-08-16.
  2. 2.0 2.1 Mölsä PK, Marttila RJ, Rinne UK (1986). "Survival and cause of death in Alzheimer's disease and multi-infarct dementia". Acta Neurologica Scandinavica. 74 (2): 103–7. PMID 3776457. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  3. 3.0 3.1 Bowen JD, Malter AD, Sheppard L; et al. (1996). "Predictors of mortality in patients diagnosed with probable Alzheimer's disease". Neurology. 47 (2): 433–9. PMID 8757016. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M (2003). "Functional transitions and active life expectancy associated with Alzheimer disease". Arch. Neurol. 60 (2): 253–9. PMID 12580712. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 5.2 Mölsä PK, Marttila RJ, Rinne UK (1995). "Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia". Acta Neurologica Scandinavica. 91 (3): 159–64. PMID 7793228. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  6. Larson EB, Shadlen MF, Wang L; et al. (2004). "Survival after initial diagnosis of Alzheimer disease". Ann. Intern. Med. 140 (7): 501–9. PMID 15068977. Unknown parameter |month= ignored (help)
  7. Jagger C, Clarke M, Stone A (1995). "Predictors of survival with Alzheimer's disease: a community-based study". Psychol Med. 25 (1): 171–7. PMID 7792352. Unknown parameter |month= ignored (help)
  8. 8.0 8.1 Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (2005). "Alzheimer disease and mortality: a 15-year epidemiological study". Arch. Neurol. 62 (5): 779–84. doi:10.1001/archneur.62.5.779. PMID 15883266. Unknown parameter |month= ignored (help)